COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation

被引：0
|
作者：
Fumiaki Sato
Atsunobu Sagara
Kaede Tajima
Shotaro Miura
Kenjiro Inaba
Yusuke Ando
Teruaki Oku
Takashi Murakami
Yoshinori Kato
Tetsuro Yumoto
机构：
[1] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Laboratory of Analytical Pathophysiology
[2] Josai University,Laboratory of Clinical Pathology, Faculty of Pharmacy
[3] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Department of Microbiology
[4] Saitama Medical University,Department of Microbiology, Faculty of Medicine
[5] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Laboratory of Biopharmaceutics and Analytical Science
来源：
Breast Cancer Research and Treatment | 2022年 / 194卷
关键词：
COL8A1; Triple-negative breast cancer; Hypoxia; Focal adhesion kinase; Tumor growth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：243 / 256
页数：13
相关论文
共 50 条
  • [31] UCHL1 promotes cancer stemness in triple-negative breast cancer
    Tian, Chuntao
    Liu, Ying
    Liu, Yixiong
    Hu, Peizhen
    Xie, Shenglong
    Guo, Yu
    Wang, Hui
    Zhang, Zhiyong
    Du, Liuyang
    Lei, Binhua
    Wang, Yingping
    Xue, Lingfei
    Zhang, Dong
    Su, Jing
    Zhang, Xiaotong
    Zhang, Ruiwen
    Chen, Jiaohong
    Zhang, Xiangqian
    Chen, Ligang
    Li, Mingyang
    Jia, Qingge
    Song, Junyang
    Liu, Jin
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 240
  • [32] Ketogenesis promotes triple-negative breast cancer metastasis via calpastatin β-hydroxybutyrylation
    Jiang, Haoran
    Zeng, Yuan
    Yuan, Xiaoye
    Chen, Liwen
    Xu, Xuni
    Jiang, Xue
    Li, Quan
    Li, Gang
    Yang, Han
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [33] β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer
    Yin, Hsin-Ling
    Wu, Chun-Chieh
    Lin, Chih-Hung
    Chai, Chee-Yin
    Hou, Ming-Feng
    Chang, Shu-Jyuan
    Tsai, Hung-Pei
    Hung, Wen-Chun
    Pan, Mei-Ren
    Luo, Chi-Wen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09):
  • [34] Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
    Li, Ting
    Zhang, Qunling
    Zhang, Jian
    Yang, Gong
    Shao, Zhimin
    Luo, Jianmin
    Fan, Minhao
    Ni, Chen
    Wu, Zhenhua
    Hu, Xichun
    BMC CANCER, 2014, 14
  • [35] Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer
    Li, Ke
    Xu, Kun
    He, Ye
    Yang, Yulu
    Tan, Meijun
    Mao, Yulan
    Zou, Yanan
    Feng, Qian
    Luo, Zhong
    Cai, Kaiyong
    ACS NANO, 2023, 17 (05) : 4667 - 4687
  • [36] A Self-Amplifying Photodynamic Biomedicine for Cascade Immune Activation Against Triple-Negative Breast Cancer
    Feng, Xianquan
    Zhang, Yan
    Lin, Wanjing
    Li, Jing
    Wu, Fei
    Lu, Qingyu
    Song, Hongtao
    Zhang, Hao
    Lan, Fenghua
    Lu, Jun
    SMALL, 2025, 21 (09)
  • [37] Rujifang inhibits triple-negative breast cancer growth via the PI3K/ AKT pathway
    Jia, Wenyu
    Lin, Xuan
    Chen, Xuezhang
    Li, Hongliang
    Zhang, Xingru
    Zhang, Yuzhuo
    Chen, Yinsong
    Wang, Bin
    Chen, Xikang
    Chen, Ju
    Tian, Huaqin
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 327
  • [38] cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
    Sohn, Joohyuk
    Liu, Shuying
    Parinyanitikul, Napa
    Lee, Jangsoon
    Hortobagyi, Gabriel N.
    Mills, Gordon B.
    Ueno, Naoto T.
    Gonzalez-Angulo, Ana M.
    JOURNAL OF CANCER, 2014, 5 (09): : 745 - 753
  • [39] Oxygen-rich chemotherapy via modified Abraxane to inhibit the growth and metastasis of triple-negative breast cancer
    Meng, Lingtong
    Gan, Shaoju
    Zhou, Ya
    Cheng, Yali
    Ding, Yawen
    Tong, Xiaoning
    Wu, Jinhui
    Hu, Yiqiao
    Yuan, Ahu
    BIOMATERIALS SCIENCE, 2019, 7 (01) : 168 - 177
  • [40] Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry
    Sun, Huizhi
    Zhang, Danfang
    Yao, Zhi
    Lin, Xian
    Liu, Jiameng
    Gu, Qiang
    Dong, Xueyi
    Liu, Fang
    Wang, Yi
    Yao, Nan
    Cheng, Siqi
    Li, Linqi
    Sun, Shuya
    CANCER BIOLOGY & THERAPY, 2017, 18 (04) : 205 - 213
12345